Investor Relation
Stock Performance
Stock Quote |
||
0.600 |
||
| UMediC Group Berhad – 0256 | ||
| Date | 20-11-2024 05.00 PM | |
| Market | MAIN MARKET | |
| Sector | Health Care Equipment & Services | |
| Change | - | |
| Percentage Change | - | |
| Volume (’00) | 310 | |
| Buy Volume (’00) | 350 | |
| Buy | 0.595 | |
| Sell | 0.600 | |
| Sell Volume (’00) | 217 | |
| Open | 0.600 | |
| High | 0.600 | |
| Low | 0.600 | |
News Alert
Register for our news alert and receive our company’s latest news & annoucements.
IR Contact
Ng Sze Hui
Legal Compliance Adviser
+604-585 5229 (EXT: 106)
ir@umedic.com.my
04 Sep 2024
Quarterly rpt on consolidated results for the financial period ended 31/07/2024
01 Aug 2024
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Commencement of Members’ Voluntary Winding Up of Subsidiaries
10 Jun 2024
Quarterly rpt on consolidated results for the financial period ended 30/04/2024
29 Apr 2024
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) TRANSFER
24 Apr 2024
Transfer of Listing
18 Apr 2024
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) TRANSFER
05 Apr 2024
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED TRANSFER
03 Apr 2024
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED TRANSFER
11 Mar 2024
Quarterly rpt on consolidated results for the financial period ended 31/01/2024
06 Mar 2024
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) SPECIAL ISSUE
30 Jan 2024
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR LIM TAW SEONG
30 Jan 2024
Changes in Director’s Interest (Section 219 of CA 2016) – MR LIM TAW SEONG
30 Jan 2024
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
16 Jan 2024
General Meetings: Outcome of Meeting
11 Jan 2024
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED SPECIAL ISSUE
04 Dec 2023
Quarterly rpt on consolidated results for the financial period ended 31/10/2023
04 Dec 2023
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED TRANSFER
27 Nov 2023
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED TRANSFER
14 Nov 2023
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED SPECIAL ISSUE
03 Nov 2023
Annual Report & CG Report – 2023
02 Nov 2023
General Meetings: Notice of Meeting
01 Nov 2023
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED SPECIAL ISSUE
30 Oct 2023
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) PROPOSED SPECIAL ISSUE
19 Oct 2023
Change in Boardroom – DATO DR TEH KENG HWANG
(Amended Announcement)
05 Oct 2023
Change in Boardroom – MR LAU CHEE KHEONG
05 Oct 2023
Change in Boardroom – DATO DR TEH KENG HWANG
29 Sep 2023
Annual Audited Accounts – 31 Jul 2023
12 Sep 2023
Quarterly rpt on consolidated results for the financial period ended 31/07/2023
07 Jun 2023
Quarterly rpt on consolidated results for the financial period ended 30 Apr 2023
10 Mar 2023
Changes in Director’s Interest (Section 219 of CA 2016) – MR LIM TAW SEONG
10 Mar 2023
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
10 Mar 2023
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR LIM TAW SEONG
06 Mar 2023
Change in Boardroom – DR NG CHIN LIANG
06 Mar 2023
Change in Boardroom – MISS NG SZE HUI
06 Mar 2023
Quarterly rpt on consolidated results for the financial period ended 31 Jan 2023
31 Jan 2023
OTHERS
UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) EMPLOYEES SHARE GRANT SCHEME OF UP TO 15% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY (EXCLUDING TREASURY SHARES, IF ANY) AT ANY POINT OF TIME DURING THE DURATION OF THE SCHEME FOR THE ELIGIBLE DIRECTORS AND EMPLOYEES OF THE COMPANY AND ITS SUBSIDIARY COMPANIES (EXCLUDING SUBSIDIARY COMPANIES WHICH ARE DORMANT) (“SGS”)
10 Jan 2023
GENERAL MEETINGS: Outcome of Meeting
02 December 2022
Quarterly rpt on consolidated results for the financial period ended 31 Oct 2022
30 November 2022
Annual Report & CG Report
29 November 2022
General Meetings: Notice of Meeting
11 November 2022
Annual Audited Accounts – 31 Jul 2022
13 September 2022
Quarterly rpt on consolidated results for the financial period ended 31 Jul 2022
25 July 2022
Initial Public Offering
22 July 2022
Quarterly rpt on consolidated results for the financial period ended 30 Apr 2022
18 July 2022
OTHERS UMEDIC GROUP BERHAD (“UMC” OR “COMPANY”) INITIAL PUBLIC OFFERING (“IPO”) IN CONJUNCTION WITH THE LISTING OF UMC ON THE ACE MARKET OF BURSA MALAYSIA SECURITIES BERHAD
06 July 2022
Timetable for IPO
06 July 2022
IPO Prospectus
Board Charter
Code of Conduct and Ethics
Directors’ Fit and Proper Policy
Audit and Risk Management Committee
Remuneration Policy
Nomination Committee
Remuneration Committee
Anti Bribery and Anti Corruption Policy
Whistleblowing Policy
Risk Management Handbook
Prospectus
Quarterly Report
Annual Report
AGM/EGM
Latest Circular
Quarterly Report
Quarterly Report Q4 2024
Quarterly rpt on consolidated results for the financial period ended 31/07/2024
Quarterly Report Q3 2024
Quarterly rpt on consolidated results for the financial period ended 30/04/2024
Quarterly Report Q2 2024
Quarterly rpt on consolidated results for the financial period ended 31/01/2024
Quarterly Report Q1 2024
Quarterly rpt on consolidated results for the financial period ended 31 Oct 2023
Quarterly Report Q4 2023
Quarterly rpt on consolidated results for the financial period ended 31 Jul 2023
Quarterly Report Q3 2023
Quarterly rpt on consolidated results for the financial period ended 30 Apr 2023
Quarterly Report Q2 2023
Quarterly rpt on consolidated results for the financial period ended 31 Jan 2023
Quarterly Report Q1 2023
Quarterly rpt on consolidated results for the financial period ended 31 Oct 2022
Quarterly Report Q4 2022
Quarterly rpt on consolidated results for the financial period ended 31 Jul 2022
Quarterly Report Q3 2022
Quarterly rpt on consolidated results for the financial period ended 30 Apr 2022
Annual Report
Annual Report & CG Report - 2023
Please refer attachments below:
Annual Report & CG Report - 2022
Please refer attachments below:
AGM/EGM
2024 Annual General Meeting
Notice of Annual General Meeting
NOTICE IS HEREBY GIVEN THAT the Third Annual General Meeting (“3rd AGM”) of UMediC Group Berhad (“UMC” or the “Company”) will be held at Sri Mas Ballroom, Level 4, Bayview Hotel Georgetown Penang, 25-A Farquhar Street, 10200 George Town, Pulau Pinang on Tuesday, 16 January 2024 at 10.30 a.m.
Related document:
2023 Annual General Meeting
Notice of Annual General Meeting
NOTICE IS HEREBY GIVEN THAT the Second Annual General Meeting (“2nd AGM”) of UMediC Group Berhad (“UMC” or the “Company”) will be held at Sri Mas Ballroom, Level 4, Bayview Hotel Georgetown Penang, 25-A Farquhar Street, 10200 George Town, Pulau Pinang on Tuesday, 10 January 2023 at 10.30 a.m.
Related document:
General Stock Info
| Stock Code | 0256 |
| Stock Short Name | UMC |
| ISIN Code | MYQ0256OO006 |
| Sector Classification | Health Care |
| Subsector Classification | Health Care Equipment & Services |
Corporate Structure
Board of Directors
Dato’ Ng Chai Eng - Non-Independent Non-Executive Chairman
- Appointed on 7 October 2021
- Holds a Certificate in Administrative Management and a Certificate in Production and Quality Control Management from the Center of Business Studies, London in 1990
- He is the co-founder of the Group as an investor and not involved in the business operations
- He currently sits on the Board of UWC Berhad as an Executive Director/ Group Chief Executive Officer and several private limited companies
Lim Taw Seong - Executive Director/Chief Executive Officer
- Appointed on 22 April 2021
- Bachelor of Engineering (Mechanical) from Universiti Teknologi Malaysia in 2003
- He has secured distributorships from multiple established international medical device companies
- He is responsible for the overall strategy and corporate direction of the Group, including sales, marketing initiatives, general management, resources planning and business development
Dr Pakirisamy Baskaran A/L P Thangavelu - Independent Non-Executive Director
- Appointed on 7 October 2021
- Bachelor of Medicine and Surgery from University of Madras, India in 1989
- Master of Obstetrics and Gynaecology from University of Malaya in 1998
- He was gazetted as a subspecialist in Maternal Fetal Medicine in 2004
- He served the Ministry of Health for 25 years
- He was the head of Maternal Fetal Medicine unit in Hospital Kuala Lumpur
Tan Chye Suan - Independent Non-Executive Director
- Appointed on 7 October 2021
- Bachelor of Law (Hons) from University of Malaya in 1992
- She was admitted as an advocate and solicitor in the High Court of Malaya in 1993
- She is a member of the Disciplinary Committee of the Advocates’ & Solicitors’ Disciplinary Board
- Life member of Women Centre for Change and Federation of Women’s Lawyers
Lee Yee Wooi - Independent Non-Executive Director
- Appointed on 7 October 2021
- Bachelor of Accounting (Hons) from University of Malaya in 1997
- Member of Malaysia institute of Accountants since 2000
- He currently sits on the Board of Heng Huat Resources Group Berhad as an Independent Non-Executive Director and several private limited companies
Dato' Dr. Teh Keng Hwang - Independent Non-Executive Director
- Appointed on 5 October 2023
- Medical Degree M.B.B.S from University of Malaya in 1978
- Ahli Mahkota Kedah from the Sultan of Kedah in 2003
- Kurniaan Dato’ Setia Diraja Kedah (D.S.D.K) in 2007
- She currently is Professor Paediatrics at University Islam Antarabangsa Sultan Abdul Halim Muadzam Shah (UniSHAMS), Kedah
Ng Sze Hui - Alternate Director to Dato’ Ng Chai Eng
- Appointed on 6 March 2023
- Bachelor of Laws – London School of Economics and Political Science
- Master of Laws and Bar Professional Training Course – City, University of London
- She currently sits on the Board of UMC Group Berhad as an Alternate Director to Dato’ Ng Chai Eng and private limited companies